 |
Protein C concentrate |
|---|---|
| Trade Name | Protein C Concentrate (Human) Vapor Heated, Immuno |
| Orphan Indication | For replacement therapy in patients with congenital or acquired protein C deficiency for the prevention and treatment of warfarin-induced skin necrosis during oral anticoagulation |
| USA Market Approval | USA |
| USA Designation Date | 1992-06-19 00:00:00 |
| Sponsor | Immuno Clinical Research Corp.;750 Lexington Avenue;New York, New York, 10022 |
